Triple receptor agonist — 30mg/3ml research vial
Price: $380 | Purity: >99% | Out of Stock
RTA GLP-3 30mg is a high-dose research vial of the triple agonist compound studied for its combined activity at GLP-1, GIP, and glucagon receptors. This 30mg/3ml vial is designed for extended research protocols. Studies have investigated its potential effects on energy expenditure, glucose homeostasis, lipid metabolism, and appetite regulation through a multi-receptor mechanism. The triple agonist approach has generated significant scientific interest for its potential to address multiple metabolic parameters simultaneously.